The Most Trusted Leaders in Healthcare to Watch in 2025 April2025

April 2025

Personalized Medicine A New Era of Care

Value-Based Care A New Paradigm for Healthcare

to Watch in

2025

Dr Shubhadeep Sinha

Senior Vice President of Development and Medical Director

Hetero Group of Companies

Dr Shubhadeep

Sinha

Fostering A Healthier Planet by the Pharmaceutical Industry

2025

A READER LIVES A THOUSAND LIVES BEFORE HE DIES . . .

THE MAN WHO NEVER READS LIVES ONLY ONE.

Editors Note

Pillars of Patient Trust:

Healthcare Leaders to Watch in 2025

W

hat is accomplished making leadership truly count is that it exists way beyond management in the world of healthcare into true commitment to the essential well-being of the patient, ethical practice, and relentless pursuit of excellence. Emerging and immersed in the field of medicine and with a view to the future, some leaders will be recognized as shining beacons of trust, individuals whose vision and actions of investment in the patient, practitioner, and whole system instill confidence. All these individuals place priority on patient safety, nurture innovation with integrity, and foster a culture of empathy and transparency in their organizations.

Most trusted healthcare leaders regard patient welfare above all else in every decision they make. Their allegiance extends well beyond clinical outcomes to embracing the whole patient experience: ensuring compassionate care, positive communication, and honoring individual needs and preferences. These leaders know that confidence is granted through uniform demonstration of their proficiency and competence, integrity, and genuine concern for the good of those whom they serve. Their passionate leadership prompts a patient to be safe, heard, and empowered in his/her journey of recovery.

Also, as much as innovation is a hallmark of focus for these trusted leaders, they appreciate technology and research includes the promise of genuine advances to medical care.

However, their forward-looking vision is invariably tethered in a firm sense of ethics that upholds responsible and equitable application of innovations absolutely intended to enhance patient outcomes and access to care. They cultivate a culture of learning and improvement, encouraging teams to explore new territories while doing so with utmost vigilance regarding safety and efficacy.

Moreover, leadership among these trusted individuals is

synonymous with accountability and transparency. They realize the value of open communication paths with patients, intra-organization members, and outside communities. They cultivate a culture in which mistakes are confronted, lessons are discussed and learned, and systems are modified always with the intent of improving patient safety and the quality of care. This investment in transparency nurtures trust and instills a sense of partnership with those they seek to help.

Beyond time, ‘The Most Trusted Leaders in Healthcare to Watch in 2025,’ of Insights Success India, will still put these core principles into practice. These will be the leaders who are ethically perfect in both clinical and administrative practice but also deeply endowed with compassion, integrity, and steady commitment to the well-being of those they serve. Such healthcare leadership operates by patientcenteredness and resilient systems of health care inspired by trust and treating all with utmost care; they are the strongholds for surety about an effective health future.

Gaurav PR Wankhade Managing Editor

COVER STORY

08 Dr Shubhadeep Sinha Fostering A Healthier Planet by Revolutionizing the Pharmaceutical Industry

C O N T E 18 N 26 T

ARTICLES 22 Personalized Medicine Ushering in a New Era of Care

32 Value-Based Care A New Paradigm for Healthcare

PROFILES The Hope Weaver:

Dr Ambika Patange's Journey to Parenthood Dreams

A Trusted Healthcare Custodian –

Dr Bhuvan Nagpal Pioneering Excellence in Diagnostics and Oral Pathology

sales@insightssuccess.in Editor-in-Chief Managing Editor Assisting Editor

EDITORIAL TEAM

Visualizer

Pooja M. Bansal Gaurav PR Wankhade Kedar Borgaonkar

DESIGN TEAM

Sandeep Tikode

Art & Design Director

Rahul Shinde

Art & Design Editor

Sarita Bhagat

Asst. Designers

Nagaraj Patil & Satish Garde

Vice President

Swapnali Vasaikar

Asst.Vice President

Tejaswini Whaval

Sr. BDE

SALES TEAM

Roshni Pamnani

DEVELOPMENT TEAM

April, 2025 Corporate Offices:

Insights Success Media and Technology Pvt. Ltd. Survey No.133/134, Brand Square, Office No. 512, Kunjir Chowk, Pimple Saudagar, Pune, Maharashtra 411027 Phone - India: +91 8793630422/24 Email: info@insightssuccess.in For Subscription: www.insightssuccessindia.com

Insights Success Media Tech LLC 555 Metro Place North, Suite 100, Dublin, OH 43017, United States Phone - (614)-602-1754 Email: info@insightssuccess.com For Subscription: www.insightssuccessindia.com

Follow us on : www.facebook.com/insightssuccess/ https://x.com/insightssuccess

Technical Head

Prachi Mokashi

Technical Specialist

Rajeshwari Avhad

Digital Marketing Manger

Sagar Lahigade

SME-SMO Executive

Prashant Rathod

SEO TEAM

We are also available on

Copyright © 2025 Insights Success Media and Technology Pvt. Ltd., All rights reserved. The content and images used in this magazine should not be reproduced or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior permission from Insights Success Media and Technology Pvt. Ltd.Reprint rights remain solely with Insights Success. Printed and Published by Insights Success Media and Technology Pvt. Ltd. RNI NUMBER: MAHENG/2018/75953

2025 Featuring

Organization

Description

Dr Ambika Patange, Fertility Management Consultatant

Samarth IVF Omerga Branch, Dr Patange Hospital

Dr Ambika Patange, part of Dr Patange Hospital Omerga since 2016, offers consultations Monday through Saturday, prioritizing patient accessibility.

Dr Bhuvan Nagpal, Centre for Oral Pathology Director and and Maxillofacial Senior Oral Pathologist Diagnostics (COPMD)

Dr Bhuvan Nagpal is a highly organized, dedicated, and experienced professional in the medical field specialized in Oral Pathology and Microbiology.

Dr Devika Chavan, Pediatrician and Neonatologist

Prolife Mother & Child Care

A Competent pediatrician with 13 years of experience, Dr Devika Chavan specializes in newborn and childhood illnesses.

Dr Santhosh Koshy, Founder. MD and Consultant Paediatrician

Little Flower Hospital Trust

Dr Santhosh Koshy is a co-founder of Koshys hospital, has been a guiding beacon to the entire team at the hospital, and as a proactive leader he steers the hospital in the right direction to provide continued quality patient care.

Dr Shubhadeep Sinha, Medical Director and Senior Vice President

Hetero Group of Companies

Dr Shubhadeep Sinha is a pharmaceutical physician with over 20 years experience, and is currently the Senior Vice President and Medical Director at Hetero Group of Companies.

Dr Shubhadeep Sinha

Senior Vice President of Development and Medical Director

Hetero Group of Companies

The Most Trusted Leaders in Healthcare to Watch in 2025

Fostering A Healthier Planet by Revolutionizing the Pharmaceutical Industry

A

transformative leader has emerged in the Indian pharmaceutical industry who successfully combines advanced medical knowledge and education, deep understanding of patient care into cuttingedge pharmaceutical and clinical research and product development.

Dr Shubhadeep Sinha rises as a beacon of trust and leadership in the healthcare and pharmaceutical sector, embodying the qualities of a visionary who is dedicated to advancing medical research, medical practice and enhancing patient care.

His journey into healthcare was the outcome of a dream nurtured by his parents, particularly his late father, Sri Debabrata Sinha, an engineering scientist and his uncle, Dr Priyabrata Sinha, a senior physician, both of whom inspired him and motivated him for commitment to the medical profession. Influenced by the remarkable stories of eminent doctors and researchers, Dr Shubhadeep's passion for medicine was ignited during his childhood, setting the stage for a distinguished career.

The Beginning of a Compassionate Leadership Dr Shubhadeep's formal medical education (MBBS) at Mumbai was pivotal in shaping his foundation as a medical professional. His undergraduate education were during golden era of distinguished medical luminaries and professors and medical teachers including renowned figures such as Prof Dr Pragnya Pai, Prof Dr Nilima Kshirsagar, Prof Dr Sharadini Dahanukar, Prof Dr GH Tilwe, Prof Dr Milind Nadkar, Prof Dr Shashank Joshi, Prof Dr Kirti Patel, Prof Dr RD Bapat, Prof Dr SK Mathur, Prof Dr Avinash Supe, Prof Dr SK Bhattacharya, Prof Dr Walter Vaz, Prof Dr Uday Khopkar, Prof Dr Abhay Dalvi and many other learned teachers of the illustrious Seth GS Medical College & KEM hospital, which was then ranked as the best medical institution in India for both patient care and advanced medical research.

This awareness of medical research and affinity for studying medicine propelled him to pursue further Doctor of Medicine (MD) from TN Medical College and BYL Nair Hospital, Mumbai further solidifying his commitment to evidence-based medicine and medical research.

With over 25 years of experience in the pharmaceutical industry, Dr Shubhadeep has held significant roles at leading pharma organizations, including Glenmark, Organon, Indigene and Dr Reddy’s Laboratories.

Innovation is the cornerstone of pharmaceutical development and continued growth.

His ascent to the position of Medical Director and Senior Vice President at Hetero Group of Companies highlights his expertise in global clinical research, pharmacovigilance, and medical affairs. His leadership in these areas has been instrumental in driving innovation and ensuring the safety and efficacy of new drugs, biosimilars, and generics.

Dr Shubhadeep's commitment to continuous learning is evident through his completion of various fellowships, including those in Diabetology and Public Health from UK, and postgraduate diploma in infectious disease (Australia), masters in hospital and healthcare management, which have enriched his understanding of public health issues and clinical approaches.

His teaching experiences at institutions like Kasturba Medical College and IGIMS, Patna, have further reinforced his dedication to knowledge sharing and mentorship, ensuring that the next generation of healthcare professionals is well-equipped to meet future challenges.

Benchmarking Ethos of Excellence Dr Shubhadeep emphasizes that the guiding philosophy behind his current organizations’ phenomenal success lies in its unwavering commitment to growth through advanced pharmaceutical science, medical scientific principles, and a relentless focus on quality at every level of drug manufacturing, development, and research. This multifaceted approach not only enhances the operational efficiency but also ensures that it remains at the forefront of the industry.

Solid Fiscal Discipline and Sound Strategies: In addition to its commitment to quality and scientific advancement, Dr. Sinha maintains solid fiscal discipline and sound strategies that underpin its growth trajectory. This financial prudence allows the company to invest in innovative technologies and expand its research capabilities while ensuring sustainable profitability. By balancing growth with fiscal responsibility, the organisation has established a

robust business model that supports long-term success in the pharmaceutical sector.

A Commitment to Community: Furthermore, Dr Shubhadeep’s leadership reflects a vision that extends beyond mere business metrics. He advocates for a holistic approach that encompasses ethical practices and corporate social responsibility. By prioritizing sustainable practices and community engagement, Hetero not only contributes to the healthcare sector but also positively impacts society.

This commitment to social responsibility enhances the company’s reputation and fosters a culture of trust and loyalty among stakeholders.

Leading Through Service: Dr Shubhadeep's Vision of Leadership Dr Shubhadeep articulates a profound philosophy of leadership that emphasizes service to the team and the importance of leading by example. He believes that true leadership involves lending a helping hand to colleagues and team members and providing continuous guidance,

motivation, and mentoring. "Leadership is not about interfering but about facilitation and support," he asserts, highlighting the need for leaders to empower their teams rather than dictate their actions. This approach ensures the best outcomes for the organization, regardless of the challenges faced.

At the core of Dr Shubhadeep's leadership philosophy is the understanding that teams thrive on collective effort, shared goals, and a positive atmosphere. He emphasizes that good team building requires patience and unwavering perseverance. "Every achievement and milestone is a catalyst to further success for the team," he notes, reinforcing the idea that each success, no matter how small, contributes to the larger vision and motivates team members to strive for excellence.

In his current role, Dr Shubhadeep has successfully built a medical research department from scratch over the past 14 years, growing it into a team of more than 140 highly qualified and motivated professionals in medicine, pharmacy, and life sciences. He places great importance on selecting individuals who possess a "professional hunger" and desire the opportunities that come with hard work and dedication. This focus on nurturing talent ensures that the team remains enthusiastic and committed to achieving their shared goals. Dr Shubhadeep's leadership style is characterized by a commitment to creating an environment where team members feel valued and empowered. By fostering open communication and collaboration, he cultivates a culture of trust and respect. This not only enhances team dynamics but also drives innovation and creativity within the organization.

Innovation as the Cornerstone According to Dr Shubhadeep, innovation is the cornerstone of pharmaceutical development and continued growth. He asserts that "innovation is driven by market and patient needs, as well as unmet medical needs, which provide the impetus for exploring solutions and corresponding technical advancements." This perspective underscores the critical role that innovation plays in not only addressing current healthcare challenges but also in anticipating future demands within the industry.

Dr Shubhadeep emphasizes that the organizations he has worked with have consistently adhered to these principles, which has contributed to their growth over the years. By placing a strong emphasis on understanding market dynamics and patient requirements, these organizations

Sustainability and environmental insurance are an absolute necessity to ensure a high-quality working environment.

have been able to develop products that genuinely meet the needs of healthcare providers and patients alike. This alignment with real-world demands ensures that their innovations are not only relevant but also impactful.

The pharmaceutical industry is inherently complex, with rapid advancements in technology and an ever-evolving regulatory landscape. Dr Shubhadeep believes that the ability to adapt and innovate is essential for success in this environment. Organizations must foster a culture of creativity and flexibility, enabling them to respond swiftly to emerging trends and challenges. By investing in research

and development, they can explore new therapeutic areas and enhance existing products, ultimately improving patient outcomes.

Moreover, Dr Shubhadeep advocates for collaboration across various sectors within the pharmaceutical industry.

He recognizes that partnerships with academic institutions, research organizations, and other stakeholders can drive innovation and accelerate the development of new therapies. "Collaboration is key to unlocking the full potential of pharmaceutical science," he states, highlighting the importance of shared knowledge and resources in advancing healthcare solutions.

Conquering the Crisis: Resilience in the Face of COVID-19 As the world grappled with the unprecedented challenges posed by the COVID-19 pandemic, Dr Shubhadeep and his team rose to the occasion, demonstrating remarkable resilience and innovation. "COVID-19 was a classical case of creating positivity in adversity," Dr Shubhadeep asserts, underscoring the pharmaceutical industry's crucial role in providing life-saving medicines and reducing disease burden during the crisis.

While the global economy came to a standstill, India's pharmaceutical sector, led by leaders like Dr Shubhadeep and his team, stepped up to the challenge. They rapidly developed and manufactured essential drugs like Remdesivir, Molnupiravir, Favipiravir, and Tocilizumab, as well as a COVID-19 vaccine, at the speed and scale required to meet the overwhelming demand from healthcare providers and patients worldwide. "When the world was reeling and unable to go to work, India's pharmaceutical industry stood up and be counted by developing the required drugs and vaccines," Dr Shubhadeep proudly states.

Every department at his organization worked tirelessly, despite the adverse circumstances and personal risks, to support healthcare facilities, hospitals, and patients in India and globally. This unwavering commitment to serving humanity in the face of adversity is a testament to the company's core values and the dedication of its employees.

"Every department made tremendous effort despite the adverse circumstances and risk to support the healthcare, hospitals and patients in India and worldwide," Dr Shubhadeep acknowledges, expressing his gratitude for the team's resilience and sacrifice.

As the world continues to navigate the aftermath of the pandemic, Dr Shubhadeep and his team remain steadfast in their mission to provide accessible and affordable healthcare solutions to those in need. Their unwavering dedication to serving humanity, even in the darkest of times, serves as an inspiration to all who strive to make a positive impact on the world.

Ensuring a Sustainable Healthcare Tomorrow Dr Shubhadeep emphasizes the critical importance of sustainability and environmental stewardship in the pharmaceutical industry, asserting that "sustainability and environmental insurance are an absolute necessity to ensure a high-quality working environment." His commitment to these principles reflects a broader understanding that the health of the planet is intrinsically linked to the health of its people. By prioritizing sustainable practices, organizations can create a safe and conducive environment for both employees and patients, ultimately leading to better health outcomes.

At his current organization, Dr Shubhadeep has championed initiatives aimed at reducing environmental carbon footprints, establishing a dedicated department for General Health and Safety and Environmental Management. This department plays a vital role in continuously monitoring and maintaining the company's commitment to social responsibility. By implementing rigorous environmental policies and practices, the organization not only complies with regulatory standards but also sets a benchmark for others in the industry. Dr Shubhadeep believes that proactive measures in environmental management can lead to significant improvements in operational efficiency and corporate reputation.

Moreover, Dr Shubhadeep recognizes that ensuring a sustainable healthcare future requires collaboration across various sectors. By engaging with stakeholders—including healthcare providers, regulatory bodies, and community organizations—pharmaceutical companies can develop comprehensive strategies that address both environmental and health challenges. "Collaboration is key to creating a sustainable healthcare ecosystem," he states, highlighting the necessity of working together to tackle complex issues such as climate change and public health crises.

In addition to environmental initiatives, Dr Shubhadeep advocates for the integration of sustainable practices into

the entire drug development process. This includes sourcing raw materials responsibly, minimizing waste during production, and ensuring that end products are environmentally friendly. By adopting a lifecycle approach to sustainability, pharmaceutical companies can significantly reduce their ecological impact while delivering high-quality healthcare solutions.

Ultimately, Dr Shubhadeep Sinha's vision for a sustainable healthcare tomorrow is rooted in the belief that the pharmaceutical industry has a pivotal role to play in fostering a healthier planet. Through a commitment to sustainability, collaboration, and innovative practices, organizations can not only enhance their operational effectiveness but also contribute to the overall well-being of society. By ensuring that sustainability is at the forefront of their strategies, pharmaceutical leaders can pave the way for a healthier, more sustainable future for generations to come.

When the world was reeling and unable to go to work, India’s pharmaceutical industry stood up and be counted by developing the required drugs and vaccines.

Global

Subscribe Subscribe to Insightssuccess Get Insightssuccess Magazine in print and digital format!

Check should be drawn in favor of

INSIGHTS SUCCESS MEDIA AND TECH PVT. LTD.

CORPORATE OFFICE Survey No.133/134, Brand Square, Office No. 512, Kunjir Chowk, Pimple Saudagar, Pune, Maharashtra 411027 Phone - India: +91 7410079881/ 82/ 83/ 84/ 85 Email: info@insightssuccess.in For Subscription: insightssuccessmedia.in

Visit once to know more

The Hope Weaver

Amba Patange's

Dr

Journey to Parenthood Dreams

T

he quiet hum of life, the gentle promise of new beginnings, echoes through the halls of Patange Hospital in Omerga. Here, Dr Ambika Patange, a beacon of hope for countless couples, embodies the very essence of trusted healthcare leadership. Her journey, marked by unwavering dedication and a profound commitment to her patients, has earned her a place among “The Most Trusted Leaders in Healthcare to Watch in 2025.”

“My practice is rooted in compassion and a deep understanding of the emotional journey my patients undertake,” Dr Patange states, her voice imbued with a quiet strength.

“Every consultation, every treatment, is a partnership, a shared journey towards the dream of parenthood.”

Foundations of Compassion: Building a Healthcare Legacy Dr Patange's story begins with a solid foundation, an educational journey that shaped her expertise. She earned her MBBS from Belgaum Institute of Medical Sciences in 2013 and her DGO from Jawaharlal Nehru Medical College in 2016. These formative years instilled in her not only a deep understanding of medical science but also a profound respect for the human experience.

“Education is the cornerstone of effective healthcare,” Dr Patange reflects. “My time at BIMS and JNMC provided me with the knowledge and skills necessary to navigate the complexities of reproductive medicine.”

Furthermore, Dr Patange has undergone specialized training in ART (Assisted Reproductive Technology) and obtained

18 | Insights Success

Fellowship in ART at SIMARR Samarth IVF, where she gained in-depth expertise in reproductive medicine and fertility treatments.

Dr Patange also received her advanced training under Dr. Harshalata Laddha and Dr. Kriti Pathrikar, both renowned specialists in the field.

Dr Patange adds, “Dr. Harshalata Laddha, Dr. Kriti Pathrikar, and Dr. Atish Laddha are the directors of Samarth IVF (SIVF) and have played a significant role in shaping my expertise in ART procedures.”

A Beacon of Hope: Navigating the Infertility Journey Her professional journey, spanning over eight years, is a testament to her dedication. Since July 2016, she has been a vital part of Patange Hospital, managing high-risk obstetric and gynaecological cases with unwavering expertise. Her specialization in infertility treatment, however, is where her passion truly shines.

“Infertility is a deeply personal and often challenging experience,” Dr Patange explains. “My goal is to provide my patients with the support and advanced treatments they need to overcome these challenges.”

Samarth IVF: A Sanctuary of Dreams Realized Her commitment to excellence is evident in her work at Samarth IVF Omerga Branch, located within Patange Hospital. Here, she leads a team dedicated to providing cutting-edge IVF treatments, offering renewed hope to

countless couples. The facility, recognized as the “Best IVF Center in Omerga,” is a testament to her dedication and the trust she has earned from her community.

“Samarth IVF is more than just a clinic; it's a place of hope,” Dr Patange says. “We strive to provide personalized care and advanced technologies to help our patients achieve their dreams of parenthood.”

Her dedication has not gone unnoticed. In 2024-2025, Samarth IVF was honoured with the “Best Performing Branch” award, a recognition of the significant number of patients successfully treated soon after launching operations. This achievement underscores Dr Patange's exceptional skills and her ability to deliver outstanding results, even in challenging cases.

“The 'Best Performing Branch' award is a reflection of our team's collective dedication and the trust our patients place in us,” Dr Patange acknowledges. “It motivates us to continue striving for excellence in every aspect of our work.”

Personalized Pathways: Tailoring Care with Expertise and Empathy A blend of clinical expertise and compassionate patient care characterizes Dr Patange's approach to fertility care. She understands that infertility treatment is not just a medical process; it's an emotional journey that requires empathy and understanding.

Dr Ambika Patange MBBS DGO, Fellowship in ART (Assisted Reproductive Technology), and Lead Fertility Expert

Samarth IVF Omerga

April, 2025

The Most Trusted Leaders in Healthcare to Watch in 2025 “Informed patients are empowered patients,” Dr Patange says. “We provide comprehensive counselling to help our patients understand their options and make informed decisions about their treatment.”

Beyond the Clinic: A Vision for Future Families Looking ahead, Dr Patange remains committed to advancing fertility care in Omerga and beyond. She envisions a future where access to advanced reproductive technologies is available to all, regardless of their location or socioeconomic status.

“My vision is to make advanced fertility care accessible to everyone,” Dr Patange shares. “We will continue to innovate and expand our services, ensuring that we can help more couples achieve their dreams of parenthood.”

“Every patient is unique, and their journey is their own,” Dr Patange emphasizes. “We provide personalized care, tailoring our treatments to meet the specific needs of each individual and couple.”

Accessibility and Empowerment: Bridging the Gap in Fertility Care Her commitment to patient accessibility is evident in her consultation schedule, offering appointments Monday through Saturday, both in the morning and evening. This accessibility ensures that patients can receive the care they need without disrupting their daily lives.

“Accessibility is crucial in healthcare,” Dr Patange believes. “We strive to make our services as accessible as possible, ensuring that our patients can receive timely and convenient care.”

At Samarth IVF, Dr Patange and her team offer a comprehensive range of services, including male and female fertility counselling, IVF treatment, Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and advanced semen analysis.

“We offer a full spectrum of fertility services, ensuring that our patients have access to the most advanced treatments available,” Dr Patange explains. “Our goal is to provide comprehensive care that addresses all aspects of infertility.”

Her expertise extends beyond clinical procedures. She also emphasizes the importance of patient education and counselling, empowering couples to make informed decisions about their reproductive health.

20 | Insights Success

"

"

My practice is rooted in compassion and a deep understanding of the emotional journey my patients undertake.

Every consultation, every treatment, is a partnership, a shared journey towards the dream of parenthood.

Dr Ambika Patange's work is not just about treating infertility; it's about building families and bringing hope to those who need it most. Her legacy is one of compassion, expertise, and unwavering dedication to the well-being of her patients.

The Trusted Leader: Crafting Legacies of Hope Dr Ambika Patange's story is one of unwavering dedication, profound empathy, and a relentless pursuit of excellence in reproductive healthcare. Her journey, marked by academic rigour, clinical expertise, and a deep-seated commitment to her patients, has solidified her position as one of “The Most Trusted Leaders in Healthcare to Watch in 2025.”

Her work at Samarth IVF, nestled within the familiar walls of Patange Hospital, is a testament to her vision of accessible and advanced fertility care. She understands that the path to parenthood is often fraught with emotional and physical challenges, and she strives to create a supportive and empowering environment for her patients.

“My greatest reward is seeing the joy on the faces of couples who have finally achieved their dream of having a child,” Dr Patange says, her eyes reflecting the warmth of her compassion. “It's a privilege to be a part of their journey.”

Her dedication to patient accessibility is evident in her flexible consultation schedule. Dr Patange is available for Fertility Management Consultations from Monday to Saturday, offering both morning (10:30 AM to 2 PM) and evening (6 PM to 8 PM) appointments. This ensures that her patients can seek her expertise without undue disruption to their daily lives. Sunday remains a day of rest, allowing her to recharge and continue her dedicated work.

“We understand that our patients have busy lives,” Dr Patange explains. “We strive to offer consultation times that accommodate their schedules, making it easier for them to access the care they need.”

Individuals can easily reach out through multiple channels to book an appointment with Dr Ambika Patange.

“We want to make the process of seeking fertility care as seamless as possible,” Dr Patange emphasizes.

Appointments can be scheduled by contacting her directly at +91 9986971895 or by sending an email to ambikagoje89@gmail.com. Dr Patange's practice is located at Patange Hospital, Patange Road, Ajay Nagar, Omerga – 413606, providing a central and accessible location for patients within the region.

“Our doors are always open to those seeking hope and guidance,” Dr Patange states. “We are here to support our patients every step of the way.”

Dr Ambika Patange's legacy extends beyond the walls of her clinic. She is a hope weaver, crafting stories of resilience and joy, one family at a time. Her unwavering commitment to her patients, coupled with her clinical expertise and compassionate approach, ensures that she will continue to be a guiding light for countless couples, solidifying her place as a trusted leader in healthcare for years to come.

April, 2025

Ushering in

a New Era of Care

22 | Insights Success

T

he medicine has been for ages based on a majoritytheory approach and that is medicine: creating and giving treatments usually based on average results that are observed in large populations. This has worked wonders for the confrontations against diseases; however, this technique does have its inherent weaknesses, being mainly that it considers everyone the same without paying heed to addiction.

The 21st century has heralded its own change: personalized medicine. Here is a completely new revolution in

healthcare: prescribing every medical intervention-from diagnosis through treatment to prevention-for the individual characteristics of that patient, making care much more effective, safer, and human-centered.

At the Forefront of Innovation in Healthcare At the heart of personalized medicine rests the belief that individuals themselves differ immensely among themselves for example in genetic makeup, lifestyle, and environmental exposures, which are all major determinants of the risk of

Personalized Medicine

April, 2025

disease, the natural history of the disease, and the response to therapy regarding this difference: all genomics, proteomics, metabolomics, and so advanced analytics now study these differences at the molecular level. Armed with knowledge of a patient's biological signature, the clinician would be given unprecedented insight into the very mechanism of the patient's condition, the predicted risk of subsequent diseases, and the best forms of targeted intervention.

In cancer treatment, personalized medicine probably reached its most alluring application. Conventionally, cancer treatment has greatly been categorized by site and types of tumors. However, we now know that even for same types of cancers, there are very strong genetic disturbances possessed by individuals-the disturbances that drive different behaviors of the disease and therapeutics or radiation responses. Personalized medicine in oncology deals with defining the specific genetic mutations present in a patient's tumor. With this information, oncologists can use therapies that include targeted drugs, which inhibit specifically the proteins encoded by the mutated genes to give more efficacious tumor control and less side effects than conventional cytotoxic chemotherapy. The tales of success of trastuzumab for HER2-positive breast cancer and vemurafenib for BRAF-mutated melanoma truly testify to the transformational power of this approach.

The Era of Personalized Medicine Besides cancer, personalized medicine is advancing rapidly to help treat many other diseases. Pharmacogenomics is a vital field of study in personalized medicine, dealing with how an individual's genetic makeup can influence their response to a drug. Genetic variations can influence drug metabolism, potency, and negative reactions. Knowing a patient's pharmacogenomic profile could assist clinicians to optimize drug selection and dosage to maximize therapeutic gain and minimize the potential for adverse effects. This is especially true in areas such as cardiology, psychiatry, and infectious diseases, where important differences emerge in the way various patients respond to medications.

For personalized medicine brings great promise in preventive care as well. Once genetic predisposition is detected, individuals are routed to focused screening, such as changes in lifestyle and even preventive therapies, much earlier to delay or even prevent onset, before certain known diseases-such as Alzheimer's disease, cystic fibrosis, or specific cardiovascular diseases-develop. It shifts the paradigm from treatment after-the-fact to personalized

24 | Insights Success

prevention; it can lead to greater improvements in health over time and efficiencies in dollars spent.

In addition to these, challenges are also inevitable in the application of personalized medicine. First, the delivery of complex genomic and other omics data into routine clinical practice needs to be sufficiently developed infrastructure, analytical tools, and trained health professionals for applying that information meaningfully. Moreover, ethical challenges around issues of data privacy, genetic discrimination, and equal access to these new technologies in personalized medicine need to be considered against the premise of several strong regulatory frameworks. Next, the cost of some genome sequencing and targeted therapy may be high and provide further issues regarding affordability and accessibility of the services to all patients.

The Future of Medicine Nonetheless, there is much more inertia behind such a vision. Ongoing research continues revealing the details of the dynamic interplay between genes and the environment, lifestyles, and disease development and treatment response.

Advances in artificial intelligence and machine learning are speeding the analysis of huge datasets-from which novel biomarkers and therapeutic targets are beginning to emerge.

As technology advances and costs decrease, personalized medicine will become increasingly embedded in mainstream healthcare and closer than ever to a future in which medical care is precisely tailored to each patient's unique needs, ushering in a new era of more effective, safer, and truly patient-centered care. The journey has its course, but the destination-such a future where health will be unique to each individual-is indeed promising for a healthier and equally healthy world.

A Trusted Healthcare Custodian

Dr

Bhuvan Nagpal

Pioneering Excellence in Diagnostics and Oral Pathology

I

n the labyrinth of healthcare, where the delicate balance between life and uncertainty hangs by a thread, precision is not merely a virtue; it's a lifeline. Dr Bhuvan Nagpal, a luminary in oral pathology, clinical biochemistry, and laboratory medicine, understands this fundamental truth. He stands as a beacon, illuminating the path towards a future where diagnostics are not just accurate, but transformative.

In the intricate world of healthcare, where precision determines survival, few individuals redefine the boundaries of diagnostics and patient care, Dr Nagpal acknowledges, his voice resonating with a quiet intensity.

"My commitment is to bridge the gap between oral pathology and mainstream medicine, ensuring that every patient receives the most accurate and timely diagnosis."

His journey is one of relentless pursuit, a quest to elevate the role of oral pathology from a peripheral specialty to a central pillar of healthcare. "We must recognize that oral health is inextricably linked to systemic health," Dr Nagpal emphasizes. "By integrating advanced diagnostic techniques into routine patient care, we can detect diseases earlier and improve overall patient outcomes."

Dr Nagpal's contributions span a vast spectrum, a testament to his multifaceted expertise. He is not just a clinician; he is a researcher, a policy advocate, and an educator, all driven by a singular mission. "My work is about more than just diagnosing diseases," he explains. "It’s about building a healthcare ecosystem where prevention is prioritized, and patients are empowered to take control of their health."

26 | Insights Success

His expertise in oral pathology is particularly profound, addressing a critical but often overlooked aspect of healthcare. "Oral pathology is the key to unlocking hidden clues about a patient's overall health," Dr Nagpal asserts.

"By examining oral tissues and fluids, we can identify biomarkers for a wide range of systemic diseases, from diabetes to cancer."

His research acumen is equally impressive, pushing the boundaries of diagnostic innovation. He champions the adoption of cutting-edge technologies and methodologies, striving to enhance the accuracy and efficiency of laboratory medicine. "We are constantly exploring new frontiers in diagnostics," he states. "By leveraging advancements in genomics, proteomics, and artificial intelligence, we can develop more precise and personalized diagnostic tools."

Dr Nagpal's leadership extends beyond the laboratory and clinic. He is a passionate advocate for policy changes that promote the integration of oral pathology into mainstream healthcare. "We need to educate policymakers and healthcare providers about the importance of oral health," he insists. "By raising awareness and advocating for evidence-based policies, we can ensure that oral pathology receives the attention it deserves."

His dedication to education is evident in his commitment to training the next generation of healthcare professionals. "We must invest in the education and training of future leaders in oral pathology," Dr Nagpal believes. "By equipping them with the knowledge and skills they need to excel, we can ensure the continued advancement of our field."

One of my proudest achievements is the establishment of POPMA, which I founded with the vision to promote Oral Pathology as a key discipline in laboratory medicine.

Dr Bhuvan Nagpal Laboratory Director and Senior Consultant in Head & Neck Pathology and Clinical Biochemistry Tohana Manglam Diagnostics

April, 2025

The Most Trusted Leaders in Healthcare to Watch in 2025

allowed me to delve deeper into the intricacies of clinical diagnostics, while the MBA provided me with the tools to lead and manage healthcare operations effectively." He emphasizes the importance of understanding the legal and regulatory aspects of healthcare. "The Postgraduate Diploma and LL.B. have been invaluable in navigating the complex medicolegal landscape."

"My diverse qualifications place me at the intersection of clinical practice, policy-making, and laboratory excellence," he concludes. "This allows me to approach healthcare challenges from a comprehensive standpoint, making me a trusted authority in the field of diagnostics."

Transforming Healthcare through Innovation and Leadership Dr Nagpal states, his gaze reflecting the drive that has characterized his career. "My journey has been about expanding access to quality diagnostics and setting new benchmarks for excellence." He begins by describing his early leadership experiences. "My career as a Consultant Oral Pathologist and Clinical Biochemist at Manglam Diagnostics, Hisar marked the beginning of my leadership journey. Expanding diagnostic services to multiple cities—Hansi, Jind, and Fatehabad—I played a pivotal role in setting new standards for laboratory medicine."

A Journey Rooted in Excellence Dr Nagpal reflects, his eyes tracing the path of his academic pursuits. "My qualifications represent a commitment to understanding healthcare from multiple perspectives." He begins by outlining his foundational education. "Beginning with a Bachelor of Dental Surgery (B.D.S.), I pursued a Master of Dental Surgery (M.D.S.) in Oral Pathology and Microbiology, setting the foundation for my career in diagnostic pathology."

However, his pursuit of knowledge did not stop there. "My thirst for knowledge and my vision for a holistic approach to healthcare led me to further qualifications," he explains.

He then details the additional degrees that have broadened his expertise. "M.Sc. in Biochemistry – Enhancing expertise in clinical diagnostics. MBA in Healthcare & Hospital Management – Equipping him with leadership and operational skills. Postgraduate Diploma in Medicolegal Systems & LL.B. – Strengthening his role in medicolegal and regulatory frameworks."

"Each degree has added a layer of understanding to my practice," Dr Nagpal says. "The M.Sc. in Biochemistry 28 | Insights Success

He then transitions to his current role. "Today, as the Laboratory Director and Senior Consultant in Head &

Neck Pathology and Clinical Biochemistry at Tohana Manglam Diagnostics, I continue to lead advancements in diagnostic accuracy, compliance, and reporting." He emphasizes the importance of continuous improvement and innovation in laboratory settings.

Dr Nagpal then highlights one of his most significant ventures. "One of my most significant ventures is the Center of Oral Pathology & Maxillofacial Diagnostics (COPMD), a state-of-the-art facility specializing in head and neck pathology, oral cancer, and maxillofacial diseases." He expresses his vision for this center. "COPMD is revolutionizing oral pathology by ensuring precision diagnostics, early cancer detection, and advanced laboratory investigations."

"COPMD is more than just a diagnostic center," Dr Nagpal explains. "It's a hub for innovation, where we are pushing the boundaries of what's possible in oral pathology. Our focus is on providing patients with the most accurate and timely diagnoses, which are crucial for effective treatment and improved outcomes." He believes that COPMD is a "game-changer" in the field, setting a new standard for specialized diagnostics.

POPMA: A Movement for Oral Pathologists "Beyond his clinical role, I am a leading advocate for oral pathology’s rightful recognition in mainstream healthcare,"

Dr Nagpal states, his voice filled with determination. "My work is about changing perceptions and ensuring that oral pathology takes its rightful place in the medical landscape."

He then describes his role in POPMA. "As the Founder & President of the Practicing Oral Pathologists and Microbiologists Association (POPMA), I have worked tirelessly to advocate for the recognition of oral pathology as a critical component of diagnostic medicine."

He outlines the specific goals he has pursued through POPMA. "We have worked to ensure MDS-qualified oral pathologists are authorized signatories for lab reports, standardize biopsy referral protocols, making histopathology a routine dental practice, and promote oral cancer screenings and awareness initiatives." He emphasizes the importance of these initiatives in improving patient care and raising awareness.

Dr Nagpal also highlights POPMA's commitment to gender inclusivity. "POPMA is also at the forefront of gender inclusivity in leadership, with a reserved Vice President position and one Executive Member post exclusively for women—ensuring that female oral pathologists have a strong voice in shaping the future of diagnostics."

He then provides a direct quote explaining this policy. "This policy is a reflection of our commitment to empowering women in the field, ensuring that leadership opportunities are not just available but actively reserved to foster

April, 2025

diversity and inclusion in oral pathology." says Dr Nagpal.

He sees this initiative as crucial for fostering a more equitable and representative profession.

Leading the Charge in Oral Cancer Prevention "Oral cancer remains a major public health crisis in India, with high morbidity and mortality rates due to late detection," Dr Nagpal acknowledges, his tone reflecting the urgency of the situation. "My focus is on proactive prevention and early detection, which are crucial for saving lives." He then describes his Early Oral Cancer Prevention Initiative. "My early Oral Cancer Prevention Initiative is actively working towards spreading awareness about the early signs of oral cancer through workshops and media outreach."

He elaborates on the initiative's specific goals. "We are encouraging routine biopsy referrals for suspicious oral lesions and collaborating with oncologists and researchers to improve early detection rates." He emphasizes the importance of these collaborations in creating a comprehensive approach to combating oral cancer.

"Knowledge dissemination is a vital part of my mission," Dr Nagpal states, transitioning to his research contributions.

30 | Insights Success

"My extensive research contributions include over 65 published research articles and 15 authoritative textbooks, furthering knowledge in histopathology, cytology, microbiology, and forensic odontology." He sees these publications as a means of sharing his expertise and contributing to the advancement of medical science. "Each publication is a step towards improving patient care and expanding our understanding of oral pathology," he adds.

A Multifaceted Visionary: Entrepreneur, Educator, & Policymaker Entrepreneurial Ventures in Healthcare & Medicolegal Systems "As an entrepreneur, I believe in creating opportunities for others and ensuring access to quality healthcare," Dr Nagpal states, his tone reflecting his multifaceted approach to his profession. "I founded Ravijyoti Medlab & Medicolegal Consultancy, providing expert services in NABL accreditation, diagnostic center setup, and medicolegal consulting." He emphasizes the impact of this venture. "My contributions in laboratory quality management systems have helped establish high-accuracy NABL-accredited labs in underserved areas."

He then reflects on his accomplishments. "One of my proudest achievements is the establishment of POPMA, which I founded with the vision to promote oral pathology as a key discipline in laboratory medicine. The future of healthcare depends on accurate, early, and efficient diagnostics, and I am committed to making that future a reality." He sees POPMA as a crucial step towards realizing his vision of integrated oral pathology.

"My work is driven by a belief in the power of diagnostics to transform lives," Dr Nagpal explains. "I strive to create a healthcare environment where every patient has access to the best possible care, regardless of their location or socioeconomic status."

The Gurukul of Oral Pathology Education: Making Education Accessible He then shifts his focus to education and mentorship.

"Understanding the financial barriers to quality education, I launched the Gurukul of Oral Pathology Education (GOPE), a mentorship platform offering training at a nominal ₹1 Gurudakshina." He elaborates on the purpose of GOPE. "Through GOPE, I am nurturing the next generation of oral pathologists by providing accessible, high-quality training."

As he continues to transform the landscape of medical diagnostics, Dr Bhuvan Nagpal’s legacy will be defined by his unwavering focus on quality, knowledge, and integrity.

These cornerstones, he believes, will guide oral pathology for generations to come, ensuring that the field continues to evolve and meet the ever-changing needs of patients. His dedication to innovation, education, and advocacy solidifies his position as one of "The Most Trusted Leaders in Healthcare to Watch in 2025," a true visionary in the realm of medical diagnostics.

For further information: Visit: https://drbhuvannagpal.com

Dr Nagpal then provides a direct quote, encapsulating his philosophy. "The true success of knowledge is in sharing it.

My goal is to ensure that aspiring oral pathologists receive the mentorship they need—regardless of financial constraints," he says seeing GOPE as a means of democratizing access to education and empowering future leaders in the field.

A Legacy of Dedication: Envisioning the Future "Looking ahead, my vision is clear," Dr Nagpal asserts, his gaze reflecting his ambitious plans. "To integrate oral pathology into national healthcare frameworks, to expand affordable, high-quality diagnostic centers across India, and to foster a self-sustaining ecosystem where oral pathologists are primary stakeholders in laboratory medicine." He outlines these goals with a sense of purpose, emphasizing his commitment to systemic change.

April, 2025

Value-Based Care

32 | Insights Success

A New Paradigm for

HEALTHCARE

T

he large-scale transformation happening in the healthcare field could best be described as chaos, moving from the traditional payment-for-service paradigm rewarding volume to one that rests solidly on the new paradigm of value-based care (VBC). To summarize, this new paradigm is about weighing the quality of patient outcomes against the costs incurred to deliver them, thus calling into question the reimbursement of health care providers and the very means they deliver that care. Valuebased care is more than a payment system; it is the beginning of a complete philosophy change toward the patient, efficiency, and improved health outcomes.

April, 2025

Essentially, VBC changes the definition of "value" in healthcare. It has been so because value is based on the results that are targeted, while procedure number visits are important proof in the whole paradigm of value transformation. Therefore, moving from this long-standing tradition considered high-quality care but employed unnecessary procedures and patient-and-provider partnerships in managing chronic conditions, possible underlines the high-value care and promotes the optimal patient outcomes with the control of the rising costs.

The Value-Based Healthcare Models The value-based care model rests on a number of principles.

First, patient-centeredness, on which this care rests, looks ultimately on the needs, preference and goals of the patient as considerations in decision-making. Thus, there should be a co-decision shared by patients and the entire care experience. Quality and outcomes guide the clinical activities, with joint efforts in the measurement and improvement of clinical effectiveness and patient safety while considering long-term health status in individuals and entire populations. Efficiency deals with waste-removal processes and unnecessary procedures and maximizes resources without risking quality. Lastly, but an equally important principle, is the integration and coordination of care realization, which guarantees a seamless transition through a continuum of health care places and providers and, therefore, prevents fragmentation but rather improves overall experience.

An array of underlying variables is actively promoting the shift to value-based care. Rising costs of healthcare worldwide have put tremendous pressures on individuals, governments, and payers to avail for sustainable models.

The inherent limitations of the fee-for-service arrangements, which can encourage unnecessary tests and procedures, are becoming clearer. Moreover, improvements in data analytics, technology, and our understanding of diseases have facilitated outcome measurement and tracking, thus enabling value-oriented reimbursement programs. Patients themselves require more transparency, better outcomes, and personalized experiences.

Various models of value-based care are emerging and being implemented throughout the healthcare continuum. ACOs are developed to voluntarily bring together groups of doctors, hospitals, and other providers caring for patients in a coordinated way. An ACO attempts to provide the best care possible for the patient while curbing unnecessary expenditures. In this approach, all the necessary services for

34 | Insights Success

treating a specific condition, such as a hip replacement or a heart bypass, receive one fixed payment. This motivates providers to become increasingly efficient in applying best practices throughout the entire episode of care. P4P programs compensate providers for achieving certain quality metrics and patient satisfaction scores. These financing modalities, and those similar in nature, have been devised to align financial incentives with the delivery of high-value care.

However, the value-based approach will have its challenges. Transitioning will require a heavy investment in data infrastructure, analytics capabilities, and the establishment of strong quality metric systems. Providers will have to transform workflows; foster collaboration across specialties and settings; and promote, support, and involve patients in their care. It is often involved in measuring outcomes and attributing specific interventions.

And this becomes even harder where equity in access to high-value care for all patient populations becomes an issue.

Even with all the challenges, value-based care has a lot to offer. It promises that patients will receive better health outcomes, better care experiences, and perhaps even less out-of-pocket expenditure. For providers, value-based care opens new doors in collaboration, innovative practices, and sustainable financial models that reward quality of care rather than quantity of care. For the healthcare system in general, VBC promises to bring efficiency, reduced waste, and an equitable allocation of resources-results in a healthier populace and a sustainable future for healthcare.

In Summary The value-based care is an encompassing paradigm shift in healthcare, moving away from a volume-based perspective to one where value-the best health outcomes for every dollar spent-is paramount. Though the pathway to adoption is long and may require a great deal of effort, collaboration, and innovation, this path bears the potential to create a truly patient-centered healthcare system that is sustainable and effective; therefore, value-based care will be transformational in terms of redeeming the future of healthcare. As we advance, embracing VBC principles will be critical to achieve a healthcare system that meets the needs of individuals and communities, paving the way for a healthier and sustainable tomorrow.

Leardehip

Is a daily practice, Not a title

WE ONLY LIVE once, so THINK big.